|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Best Practice
Open Access
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Form
Ethics Disclosure form
All issues
Ahead-of Print Articles
Most Read Articles
Most Cited Articles
Radiation Oncology Journal
Search
Author Index
Previous issue
> Previous issue
Table of Contents | June, 2022 Vol. 40 No.2
Previous Issue
|
Next Issue
|
Archive
In this issue:
▶ Review Article
▶ Original Article
▶ Case Report
Review Article
89
An overview of radiation-induced heart disease
Samer Ellahham
, Amani Khalouf
, Mohammed Elkhazendar
, Nour Dababo
, Yosef Manla
Radiat Oncol J.
2022;40(2):89-102. Published online 2022 Jun 21 DOI:
https://doi.org/10.3857/roj.2021.00766
Full text
PubReader
ePub
PDF
Web of Science 12
Crossref 24
Original Articles
Clinical Investigations
103
Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
Candan Demiroz Abakay
, Sonay Arslan
, Meral Kurt
, Sibel Cetintas
Radiat Oncol J.
2022;40(2):103-110. Published online 2022 May 25 DOI:
https://doi.org/10.3857/roj.2021.00864
Full text
PubReader
ePub
PDF
Web of Science 1
Crossref 1
111
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy
, Colin S. Hill
, Shuchi Sehgal
, Lei Zheng
, Jin He
, Daniel A. Laheru
, Ana De Jesus-Acosta
, Joseph M. Herman
, Jeffrey Meyer
, Amol K. Narang
Radiat Oncol J.
2022;40(2):111-119. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.01060
Full text
PubReader
ePub
PDF
Supplementary Material
Web of Science 10
Crossref 10
120
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee
, Joo Ho Lee
, Seong Keun Kwon
, Eun-Jae Chung
, Hong-Gyun Wu
Radiat Oncol J.
2022;40(2):120-126. Published online 2022 May 17 DOI:
https://doi.org/10.3857/roj.2021.01025
Full text
PubReader
ePub
PDF
Web of Science 2
Crossref 2
127
Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav
, Shipra Gupta
, Divya Dahiya
, Ankita Gupta
, Arun Singh Oinam
Radiat Oncol J.
2022;40(2):127-140. Published online 2022 Jun 20 DOI:
https://doi.org/10.3857/roj.2021.01053
Full text
PubReader
ePub
PDF
Web of Science 6
Crossref 6
141
Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Chawalit Lertbutsayanukul
, Manida Pitak
, Chonnipa Nantavithya
Radiat Oncol J.
2022;40(2):141-150. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.00927
Full text
PubReader
ePub
PDF
Supplementary Material
Web of Science 3
Crossref 2
151
Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Christos Nanos
, Vasilios Souftas
, Athanasios Zissimopoulos
, Michael I. Koukourakis
Radiat Oncol J.
2022;40(2):151-161. Published online 2022 Jun 20 DOI:
https://doi.org/10.3857/roj.2021.01032
Full text
PubReader
ePub
PDF
Web of Science 3
Crossref 3
Case Report
162
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Rahul N. Prasad
, Peter J. Kobalka
, Haley K. Perlow
, Daniel M. Prevedello
, Dukagjin M. Blakaj
, Raju R. Raval
, Joshua D. Palmer
Radiat Oncol J.
2022;40(2):162-168. Published online 2022 May 20 DOI:
https://doi.org/10.3857/roj.2021.01074
Full text
PubReader
ePub
PDF
Web of Science 1
Crossref 1
Journal Impact Factor 1.8